Skip to main content

Drug Interactions between cefpodoxime and Rebyota

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

cefpodoxime fecal microbiota, live

Applies to: cefpodoxime and Rebyota (fecal microbiota, live)

If you are currently being treated with cefpodoxime, let your doctor know before you receive fecal microbiota, live. Using cefpodoxime together with fecal microbiota, live or 1 to 3 days before receiving treatment with fecal microbiota, live may decrease the effects of fecal microbiota, live. In addition, it may be advisable to avoid using any oral formulations of cefpodoxime for 8 weeks after treatment with fecal microbiota, live. Your doctor may want to separate the dosing times by a few days or weeks to reduce the risk of an interaction, or they may want to monitor you more closely to make sure the medications are working as intended. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Drug and food interactions

Moderate

cefpodoxime food

Applies to: cefpodoxime

Food can enhance the levels of cefpodoxime tablets in your body. Take the cefpodoxime tablets with food to increase absorption by the body. The cefpodoxime suspension can be taken with or without food. You should take cefpodoxime at the same time each day.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer